Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

Clinical trial NCT00625573 · COMPLETED

Trial details

NCT number: NCT00625573
Sponsor: Mt. Sinai Medical Center, Miami
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2007-09-01
Primary completion: 2009-02-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.